We are live on ! Find out more
CCA

Checchi Capital Advisers Portfolio holdings

AUM $2.22B
1-Year Est. Return 23.18%
This Fund
S&P 500
This Quarter Est. Return
-0.26%
1 Year Est. Return
+23.18%
3 Year Est. Return
+67.97%
5 Year Est. Return
+70.88%
10 Year Est. Return
+253.8%
AUM
$379M
AUM Growth
+$40.8M
Cap. Flow
+$15.9M
Cap. Flow %
4.19%
Top 10 Hldgs %
36.8%
Holding
386
New
30
Increased
207
Reduced
123
Closed
18

Top Buys

Rank Stock Value
1
EWY icon
iShares MSCI South Korea ETF
EWY
+$2.11M
2
INDA icon
iShares MSCI India ETF
INDA
+$1.9M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$1.45M
4
BWX icon
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
+$1.43M
5
EWT icon
iShares MSCI Taiwan ETF
EWT
+$1.24M

Top Sells

Rank Stock Value
1
MGK icon
Vanguard Morningstar Mega Cap Growth ETF
MGK
+$574K
2
MBB icon
iShares MBS ETF
MBB
+$390K
3
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$374K
4
LO
LORILLARD INC COM STK
LO
+$372K
5
VOT icon
Vanguard Morningstar Mid-Cap Growth ETF
VOT
+$353K

Sector Composition

Rank Sector Weight
1 Miscellaneous 54.08%
2 Healthcare 8.12%
3 Technology 7.53%
4 Financials 7.02%
5 Consumer Staples 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
51
Chevron
CVX
$392B
$1.63M 0.43%
16,903
+381
+2% +$40K
T icon
52
AT&T
T
$174B
$1.63M 0.43%
60,603
+5,339
+10% +$138K
QCOM icon
53
Qualcomm
QCOM
$176B
$1.61M 0.42%
25,679
-1,520
-6% -$104K
SHY icon
54
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$1.57M 0.41%
18,479
+1,192
+7% +$101K
GILD icon
55
Gilead Sciences
GILD
$185B
$1.55M 0.41%
13,202
-884
-6% -$96.6K
NVS icon
56
Novartis
NVS
$294B
$1.52M 0.4%
17,294
+1,974
+13% +$181K
PM icon
57
Philip Morris
PM
$297B
$1.52M 0.4%
18,905
-440
-2% -$36.2K
IEMG icon
58
iShares Core MSCI Emerging Markets ETF
IEMG
$162B
$1.4M 0.37%
29,208
-2,104
-7% -$106K
VCLT icon
59
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.85B
$1.34M 0.35%
15,672
+677
+5% +$60.6K
BAC icon
60
Bank of America
BAC
$428B
$1.34M 0.35%
78,508
+2,386
+3% +$39.3K
DE icon
61
Deere & Co
DE
$168B
$1.33M 0.35%
13,682
+95
+0.7% +$8.64K
IONS icon
62
Ionis Pharmaceuticals
IONS
$10.4B
$1.32M 0.35%
+22,859
New +$1.45M
TM icon
63
Toyota
TM
$227B
$1.26M 0.33%
9,437
+1,145
+14% +$158K
C icon
64
Citigroup
C
$223B
$1.22M 0.32%
22,076
+2,132
+11% +$116K
TJX icon
65
TJX Companies
TJX
$148B
$1.18M 0.31%
35,700
-240
-0.7% -$7.98K
PEP icon
66
PepsiCo
PEP
$191B
$1.07M 0.28%
11,501
-2,447
-18% -$234K
BRK.B icon
67
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.06M 0.28%
7,761
+519
+7% +$74K
GSK icon
68
GSK
GSK
$101B
$1.05M 0.28%
20,160
+1,066
+6% +$60K
MO icon
69
Altria Group
MO
$113B
$1.04M 0.27%
21,274
-1,137
-5% -$57.6K
AMZN icon
70
Amazon
AMZN
$2.76T
$1.04M 0.27%
47,880
-4,800
-9% -$100K
CMCSA icon
71
Comcast
CMCSA
$93.7B
$1M 0.26%
33,394
-2,528
-7% -$74.2K
BMY icon
72
Bristol-Myers Squibb
BMY
$137B
$992K 0.26%
14,914
-588
-4% -$38.8K
EFA icon
73
CALL
iShares MSCI EAFE ETF
EFA
$79.8B
$990K 0.26%
15,600
-78,500
-83% -$5.23M
ALKS icon
74
Alkermes
ALKS
$8.2B
$972K 0.26%
+15,114
New +$925K
CVS icon
75
CVS Health
CVS
$119B
$958K 0.25%
9,137
-1,075
-11% -$110K
1 2
3
4 5

Similar funds

MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2.22B AUM 32.92% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $2.21B AUM 22.85% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $2.23B AUM 38.37% 1-Year Est. Return

Checchi Capital Advisers's Q2 2015 Portfolio in Review

As of Q2 2015, Checchi Capital Advisers held 386 positions worth $379M, up 12% from $338M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Checchi Capital Advisers deployed $15.9M of net new capital in Q2 2015, opening 30 new positions and adding to 207 existing holdings. Its largest new stake was Ionis Pharmaceuticals: 22,859 shares worth $1.32M.

By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vanguard Morningstar Mega Cap Growth ETF, an estimated $574K trimmed.

  • Checchi Capital Advisers's largest Q2 2015 buy was Ionis Pharmaceuticals: 22,859 shares worth $1.32M.
  • Checchi Capital Advisers added most to iShares MSCI South Korea ETF in Q2 2015, an estimated $2.11M increase.
  • Checchi Capital Advisers's biggest Q2 2015 reduction was Vanguard Morningstar Mega Cap Growth ETF, cutting an estimated $574K.
  • Checchi Capital Advisers fully exited Vanguard Morningstar Growth ETF in Q2 2015, selling an estimated $374K.
  • Checchi Capital Advisers's ten largest holdings make up 37% of its $379M portfolio in Q2 2015.
  • Checchi Capital Advisers opened 30 new positions and closed 18 in Q2 2015.
  • Checchi Capital Advisers's portfolio value rose 12% quarter-over-quarter to $379M.

Based on Checchi Capital Advisers's 13F filing for Q2 2015, filed 4 Aug 2015.